Attachment A 2018-2021 NIEHS DERT Grantee Survey

Attachment A 2018-2021 NIEHS DERT Grantee Survey.docx

NIEHS DERT Extramural Grantee Data Collection

Attachment A 2018-2021 NIEHS DERT Grantee Survey

OMB: 0925-0657

Document [docx]
Download: docx | pdf

Form Approved

OMB No. 0925-0657

Exp. Date 07/31/2018

(to be updated upon OMB approval)


Attachment A

DERT Extramural Grantee Data Collection Survey

Shape1

Public reporting burden for this collection of information is estimated to average 30 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to: NIH, Project Clearance Branch; 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0657). Do not return the completed form to this address.




Demographics and Background Information


Grant Number: _______________________


How did you learn about this funding opportunity?

NIEHS Website

Grants.gov

Social Media (Twitter, Linked In, etc.)

Colleague/Word of Mouth

Conference/Webinar

University-based Resource (Tech Transfer Office)

Federal Register


What is your age?

<30

30-39

40-49

50-59

60+


What degrees do you hold? (Please check all that apply)

AB, BA, BS, BSc

MA, MS, MHS, MPH, MPA, MED, MSIH

PhD, Sc.D, DSc

MD

Other clinical degree (e.g. DO, DDS, MBBS, RN)

Other please specify_______________

None


In what year did you receive your highest degree? _______________ (drop down menu)


What is your current position?__________________________________________________


How long have you held that position? _________ Years ________ Months



In what type of research do you engage? (Please check all that apply)


Indicate whether you research in a specific area was basic or applied (Please check all that apply)


Basic Applied


If your research was applied…What types of applied research? (Please check all that apply)

  • Clinical Research

  • Public Health Research

  • Health Services Research

  • Intervention Research

  • Program or Policy Research

  • Technology Innovation

  • Translational Research

  • Other please specify________


FUNDING


Please indicate which sources of selected science portfolio-related funding you have had during your career to date.

Funding Source

Please check all sources of selected science portfolio -related funding

(Please select all that apply)


Career Last 10 years

Please indicate which funding source was the primary funder for this research.


Career Last 10 years

NIEHS

NHLBI

NIAID

NICHD

Other NIH

CDC

AHRQ

FDA

EPA

HUD

NSF

Other US government (not listed above)

Foundations

Industry

University discretionary/ start-up funds

Local, state or regional government

Other, specify___________


For your NIH-funded selected science portfolio research, please indicate which types of funding you have received. (Please check all that apply).

Research (e.g., R01, R03, R21)

Program/Center (e.g., M, P and U awards)

Career Development Individual (e.g., K awards; R23, R29)

Fellowships (e.g., F awards)

Institutional Training (e.g., T32)

Technology Development (e.g., SBIR, STTR; R41-44, N43-44, U43-44)

Other funding type (specify): _______________________________________


Please describe if and how you have used NIEHS funds to leverage other resources, including monetary and non-monetary support.________________________________________________


OUTPUTS


Research Outputs


Please indicate which of the following research outputs you have produced as part of this project and provide a brief description:


Research Output

Check all that apply:

Provide a brief description.

Animal Models

Animal model developed


Biological Materials


Biological material or application identified or developed as a result of the research study


Clinical

Products

Medication, drug compounds, clinical devices (includes development and testing of these products)


Databases,

Software,

Algorithms


Database resulting from the research study


Software resulting from the research study


Algorithm resulting from the research study


License Agreements


License agreement executed for intellectual property generated by the research study.


Measurement Instruments, Assays & Methods


Measurement instrument developed by the research study


Research Data (public or restricted)

Research data generated by the research study


Economic Outcomes

Research study findings result in a cost-effective intervention for a disease, condition, or disorder



Research study findings result in enhancement of existing resources and expertise


Research study findings result in increased performance, quality, and consistency in the delivery of health care services


Health Care Outcomes

Research study findings result in clinically effective approach in the management and treatment of a disease, disorder or condition


Quality of Life

Research study findings leads to enhancement of well-being among community members


Knowledge Transfer Outputs


Please indicate which of the following knowledge transfer outputs you have produced as part of this project and provide a brief description:


Knowledge Transfer Output

Check all that apply:

Provide a brief description.

Alternative/

Informal Dissemination


Research study is referred to or cited in a blog, tweet, wiki or other alternative mode of dissemination.


Research study is cited in a presentation, speech or teaching materials.


Biological Materials


Subsequent use of a particular biological material or application of the material generated by the research study in a bench study (basic science) or clinical trial study.


Preclinical data generated in support of investigational new drug (IND) application or to the receipt of an IND.


Clinical data generated in support of marketing a biological material (Biologic License Application) generated by the research study.


Clinical Guidelines

The clinical guideline refers to the research study or recommends the study for background readings.


Curriculum Guidelines


The curriculum guideline refers to the research study or recommends the study for background readings.


License Agreements


License agreement granted for use of intellectual property generated by the research study.


Mass Media

Mass media publication refers to the research study.


Material Transfer Agreements (MTA)

MTA executed for transfer of tangible property generated by the research study.


Medical Devices


Clinical trial study testing of a medical device generated by the research study.


Clinical data generated in support of marketing a medical device (510(k); Investigational Device Exemption, IDE; or Premarket Approval, PMA) generated by the research study.


Meta-Analyses

Research study cited in a meta-analysis.



Knowledge Transfer Output

Check all that apply:

Provide a brief description.

Pharmaceutical Preparations


Subsequent use of a drug generated by the research study in a bench study (basic science/preclinical) or clinical trial study, including application and/or receipt of an Investigational New Drug Application (IND) from the FDA.


Clinical data generated in support of marketing a drug (Drug Application, NDA; Abbreviated New Drug Application, ANDA; or 505(b)(2)) generated by the research study.


Ancillary Research Studies

Ancillary research study generated as a result of the research study.


New Research Studies


New research study generated as a result of the research study.


Subject Headings/

Thesauri

New subject heading or thesauri term or phrase resulting or related to the research study is applied.



Career Development Outputs


Career Development Output

Check all that apply:

Provide a brief description.

University Leadership Positions

Serve as Center Director, Department Chair, or other university leadership position


Organizational/

Conference Leadership Position

Serve as conference chair, organizational leader (Society of Toxicology, International Society of Environmental Epidemiology, etc.)


Nominated for Membership in Prestigious Organization

Nominated for membership in prestigious organization such as Institute of Medicine, American Association for Advancement of Science, etc.


Employment Promotion

Received promotion to higher level of employment, such as next level of professor, or scientist


Obtained Tenure Status

Obtained tenure status for research or teaching position


Trained or Mentored Students

Served as a mentor or trained students in the field of selected science portfolio


Additional Training or Certification Received

Obtained additional training (K awards) or certifications within the field of environmental health science


Training/Certifications Outputs

Career Development Output

Check all that apply:

Provide additional information.

Teaching

Taught courses in the area of the selected science portfolio

Number of courses taught:

Number of students taught:

Description of courses taught:

New Investigators Recruited to NIEHS

Recruited new investigators to submit applications to NIEHS

Number of new investigators recruited (new investigator has not previously had a substantial NIH award such as an R01, P30, etc.):

Young Investigators Recruited to NIEHS

Recruited early stage investigators to submit applications to NIEHS

Number of early stage investigators recruited (early stage investigators are within 10 years of their terminal degree or medical residency):


Describe the approaches you used to include/advance young investigators.


Which of these approaches was most effective?

Describe why.


Describe the barriers you face to training the next generation of NIEHS scientists.



Dissemination Outputs


Please indicate which of the following mechanisms you have used to disseminate related knowledge and products stemming from your research. (Please check all that apply).

  • Published in peer-reviewed journals

  • Presented at scientific conferences

  • Participated in grantee meetings

  • Developed and disseminated curricula

  • Developed and disseminated interventions

  • Participated in the development of clinical guidelines

  • Developed and disseminated research tools and methods

  • Participated in workshops or trainings disseminating your research

  • Provided scientific testimony and briefings to legislators

  • Developed and published websites

  • Presented research in community forums

  • Developed fact sheets and pamphlets

  • Provided information for press releases

  • Other, please specify:_______________________________________________

As part of your research, you may have had the opportunity to engage with different types of individuals and groups. Please indicate what the nature of your personal engagement has been with each of the following groups. (Please check all that apply)

Group

Share information

Conduct joint projects or activities

Serve on boards or advisory panels

Provide formal testimony

Serve as employee or consultant

No interaction

Other researchers

University administration / program directors

Local, regional or national health officials

Environmental regulators

Food and drug regulators

Legislators and staffers

Business and industry representatives

Housing and urban development agencies

Advocacy groups

Community groups

Other : _______________________________


Commercialization Outputs


We are interested in whether your selected science portfolio -related research, regardless of funding source, has led to the development of intellectual property.


Have you applied for one or more patents?

Yes No


[IF YES] Provide the patent application number(s):____________________


[IF YES] What is the nature of your patents(s)?

  • New drug

New use of drug

Medical product or device

  • Environmental controls and services

  • New process or procedure

  • New research method

  • New gene

  • Other please specify ______________________________


Have you commercialized your innovation based on your patent(s)?

Yes No


[IF YES] How many units have you sold? _______

What is your total sales? $______


Have you licensed your innovation(s)?

Yes No


Did any Federal agencies support this work?

Yes No

[IF YES] Which other Federal agencies supported this work?

(Please check all that apply)

NIEHS

NHLBI

NIAID

NICHD

Other NIH

CDC

AHRQ

FDA

EPA

HUD

NSF

Other US government (not listed above)



Have you spun-off or started a new company based on your research related to the selected science portfolio?

Yes No


Community Partnership Outputs


Describe any community outreach outputs produced by your project, such as Outreach visits, interventions, curriculums, etc.: ________________________________________

______________________________________________________________________


Describe the target audience (include specific numbers of people reached if possible):

______________________________________________________________________

______________________________________________________________________


Describe the goal of the community partnership: _______________________________

______________________________________________________________________


Describe the ways community partners participated in the project: ________________

______________________________________________________________________


Describe any leadership roles community partners had in the project: ______________

______________________________________________________________________


IMPACTS


We are interested in assessing whether you think your research will have effects on long term outcomes (now or in the near future) through a variety of pathways, including clinical practice changes, reduced exposure to environmental hazards, or changes in public behavior and advocacy. For each of the following items, please mark the ’current’ box if you believe your research has already affected change in this area and the ‘future potential’ box if you believe it has the potential to affect change in the next 10 years.


Impact Area

Impact Timing

  1. My research has led to greater understanding of selected science portfolio disease mechanisms

Describe impact:

Current Future potential

  1. My research has led to greater understanding of individual, social, and environmental factors associated with selected science portfolio

Describe impact:

Current Future potential

  1. My research has led to improved environmental measurement techniques

Describe impact:

Current Future potential

  1. My research has led to increased evidence regarding effective interventions

Describe impact:

Current Future potential

  1. My research has led to improved environmental control techniques

Describe impact:

Current Future potential

  1. My research has led to changes in education outcomes for clinical/public health students

Describe impact:

Current Future potential

  1. My research has led to changes in education outcomes for K-12 or families

Describe impact:

Current Future potential

  1. My research has led to changes in business practices regarding selected science portfolio

Describe impact:

Current Future potential

Impact Area

Impact Timing

  1. My research has led to changes in environmental standards or regulations for change to reflect selected science portfolio

Describe impact:

Current Future potential

  1. My research has led to changes in environmental policies for selected science portfolio

Describe impact:

Current Future potential

  1. My research has led to changes in clinical practice relevant to selected science portfolio

Describe impact:

Current Future potential

  1. My research has led to changes in public knowledge and practices related to selected science portfolio prevention and control

Describe impact:

Current Future potential

  1. My research has led to increased public advocacy for selected science portfolio prevention and control

Describe impact:

Current Future potential

  1. My research has led to changes in behavior related to the field of selected science portfolio

Current Future potential


Scientific Goals and Objectives


Describe the key scientific findings associated with your funded research.


Describe the impact or potential impact of these findings on public health.


Describe the impact or potential impact of these findings on the field of XXX.


How did any workshops or meetings related to the selected science portfolio affect your project goals?


Prior to the FOA in this area, were you already conducting research in the selected science portfolio?



Describe any research objectives you were not able to achieve with the current budget allocated to this grant.




RFA Goals (if applicable)

The goals of the RFAs for this portfolio include: (list goals here.)


To what extent did your project address each of these goals?


Did the FOA encourage you to take your research in a new direction?


What obstacles are there in expanding this selected science portfolio?


Do you think a new FOA in the selected science portfolio could solicit research that would help overcome the obstacles you encountered?

Yes No


If yes, share your thoughts on how a funding opportunity could help; including development of tools or standardized measurements that are lacking, etc.:





Research Agenda


What selected science portfolio -related research topics would you like to see included among the NIEHS extramural research priorities over the next 5-10 years to address emerging science areas or areas where there are gaps in current research ________________________________________________________________________


________________________________________________________________________



Research Collaborations



Do/Did you collaborate with other grantees who are doing similar work? Yes/No



If so, describe the collaboration:_____________________________________________

______________________________________________________________________


Is there a collaborator or partner that you would like to work with more? Yes/No


If so, who and why? ______________________________________________________


What has prevented you from pursuing that relationship?_______________________


Is there anything NIEHS can do to help facilitate that relationship?________________

______________________________________________________________________






PROGRAM SUPPORT


How satisfied are you with the support you received from program staff, such as grantee meetings, communications, etc.?



Everything was Great

(5)

Mostly OK

(4)

So-So

(3)

Could have been better (2)

Provided little or no help (1)

Not Applicable

Grantee meetings







Regular communication







Workgroups







Sharepoint sites or similar web-based sharing







Webinars







Data or sample sharing







Methods or technologies







Other activities provided based on program or portfolio selected








What was the most beneficial type of support you received from program staff? And why?


Are there other support activities that NIEHS program staff could have provided that would have facilitated your research project? Yes/No


If yes, please describe:___________________________________________________


Grant Administration

Was there a budget change during the grant period?

Did you have trouble finding staff resources for the research?

Was there a change in research aim(s)? If so, please provide details.


If collaborative or consortium type funding:

Describe your participation in the current consortium.



In addition to your individual grant accomplishments, what do you see as the main accomplishments of the consortium efforts? (both methods and findings)



[if history of funding from NIEHS] How does your experience with this consortium model differ from other grants you have been involved with at NIEHS?



What do you see as the primary benefits with funding this research through a consortium?



What are the primary challenges associated with funding this research through a consortium?



To what extent have joint products emerged from the consortium (e.g., joint publications, presentations, new collaborations, shared datasets, new grants?)

What were the benefits and challenges involved in working on these joint products?



How satisfied are you with those efforts?



Do you anticipate continuing to collaborate with any of these consortium members after this grant is over? Please describe your plans.



LESSONS LEARNED (Note to OMB: this section will be customized for each portfolio or program evaluation to address unique characteristics of the portfolio or program, such as the funding mechanism used or partnering and collaboration requirements. Potential questions are provided below.)



Would you recommend that NIEHS use the consortium model in future funding announcements?



What (if anything) would you want to see done differently related to how the consortium was convened or managed?



Many grant programs today are specifically looking at research translation and the broader societal impacts of the use of research findings including informing regulation. Based on your experiences with this grant, what do you think is the best way to conduct research to translate findings to affect broader social impacts and/or to inform the regulatory process?



Are there any other lessons learned you would like to share regarding your participation in this grant?



File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleAttachment 2
AuthorBattelle
File Modified0000-00-00
File Created2021-01-20

© 2024 OMB.report | Privacy Policy